Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Viyash Scientific Limited for the company's overall valuation and market capitalisation.

Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SEQUENT stock price and chart for real-time trading data and today's change.

Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency. Review how much free cash does Viyash Scientific Limited generate to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Gokaldas Exports Limited
NSE:GOKEX
0.050x
Hypoport SE
XETRA:HYQ
0.012x
Shenzhen Sosen Electronics Co.Ltd.
SHE:301002
-0.007x
Sinon Corp
TW:1712
0.058x
Kambi Group PLC Series B
LSE:0EAW
0.089x
Nanfang Ventilator Co Ltd
SHE:300004
0.015x
Pagerduty Inc
NYSE:PD
0.094x
Yaari Digital Integrated Services Limited
NSE:YAARI
0.000x

Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. Also see balance sheet size of Viyash Scientific Limited for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs7.70 Billion
≈ $83.31 Million
Rs833.60 Million
≈ $9.02 Million
0.108x +152.16%
2024-03-31 Rs7.13 Billion
≈ $77.10 Million
Rs305.95 Million
≈ $3.31 Million
0.043x +91.28%
2023-03-31 Rs7.49 Billion
≈ $81.02 Million
Rs168.08 Million
≈ $1.82 Million
0.022x -45.73%
2022-03-31 Rs7.40 Billion
≈ $80.04 Million
Rs305.95 Million
≈ $3.31 Million
0.041x -72.03%
2021-03-31 Rs7.76 Billion
≈ $83.96 Million
Rs1.15 Billion
≈ $12.41 Million
0.148x -6.20%
2020-03-31 Rs7.32 Billion
≈ $79.15 Million
Rs1.15 Billion
≈ $12.47 Million
0.158x +1.45%
2019-03-31 Rs7.47 Billion
≈ $80.78 Million
Rs1.16 Billion
≈ $12.55 Million
0.155x +135.05%
2018-03-31 Rs6.85 Billion
≈ $74.03 Million
Rs452.39 Million
≈ $4.89 Million
0.066x +1013.61%
2017-03-31 Rs9.94 Billion
≈ $107.50 Million
Rs-71.90 Million
≈ $-777.57K
-0.007x -12597.48%
2016-03-31 Rs9.48 Billion
≈ $102.51 Million
Rs-540.00K
≈ $-5.84K
0.000x +99.94%
2015-03-31 Rs2.38 Billion
≈ $25.76 Million
Rs-235.49 Million
≈ $-2.55 Million
-0.099x +86.47%
2014-03-31 Rs613.06 Million
≈ $6.63 Million
Rs-447.85 Million
≈ $-4.84 Million
-0.731x -1803.87%
2013-03-31 Rs995.83 Million
≈ $10.77 Million
Rs-38.21 Million
≈ $-413.23K
-0.038x -116.25%
2012-03-31 Rs1.28 Billion
≈ $13.84 Million
Rs302.36 Million
≈ $3.27 Million
0.236x -37.08%
2011-03-31 Rs1.35 Billion
≈ $14.60 Million
Rs506.60 Million
≈ $5.48 Million
0.375x +148.36%
2010-03-31 Rs1.12 Billion
≈ $12.09 Million
Rs168.95 Million
≈ $1.83 Million
0.151x +223.00%
2009-03-31 Rs405.20 Million
≈ $4.38 Million
Rs-49.79 Million
≈ $-538.46K
-0.123x -14561.60%
2008-03-31 Rs573.71 Million
≈ $6.20 Million
Rs487.47K
≈ $5.27K
0.001x -99.26%
2007-03-31 Rs349.24 Million
≈ $3.78 Million
Rs40.21 Million
≈ $434.91K
0.115x -68.51%
2006-03-31 Rs198.08 Million
≈ $2.14 Million
Rs72.43 Million
≈ $783.26K
0.366x --

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic
Market Cap
$529.07 Million
Rs48.92 Billion INR
Market Cap Rank
#12000 Global
#593 in India
Share Price
Rs193.72
Change (1 day)
-3.70%
52-Week Range
Rs190.05 - Rs252.00
All Time High
Rs322.89
About

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more